Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

New therapies for rare skin diseases show promise but need more research.

Methylene blue helps hair growth by protecting hair stem cells from stress.

Semaglutide may help some skin disorders but can also cause skin issues.

A rash from semaglutide may be due to propylene glycol, not the drug itself.

GLP-1RA therapy may increase the risk of hair loss.

RG and RJ gels speed up burn wound healing better than other treatments.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

GLP-1 agonists may increase the risk of hair loss.

Combining antidiabetic drugs, hormonal therapies, and lifestyle changes can improve health in women with PCOS.

Newer GLP-1 drugs like semaglutide may cause hair loss.

Tirzepatide improved symptoms and hair regrowth in a man with folliculitis decalvans.

New therapies and treatments for hair disorders, especially in curly hair, show promise.

Weight-loss drugs are not linked to suicidal thoughts.

Early detection and comprehensive treatment of PCOS are crucial due to its long-term health impacts and associated risks.

Different treatments for PCOS should be tailored to the individual, including lifestyle changes and various medications.

Women with Polycystic Ovary Syndrome (PCOS) have a higher risk of developing type 2 diabetes due to insulin resistance.

Lifestyle changes, medications, and fertility treatments can improve PCOS symptoms and prevent complications.

Continuous glucose monitoring and GLP-1 receptor agonists improve diabetes management, but personalized care and education are crucial.

Semaglutide is an effective weekly treatment for obesity, promoting weight loss and improving health, despite some side effects.

New guidelines stress early diagnosis and lifestyle changes to manage metabolic syndrome and prevent complications.

Hawthorn-probiotic postbiotic may relieve constipation in elderly.

JW0061 may be a new treatment for hair loss by promoting hair growth through WNT signaling.

Pharmacists play a crucial role in patient education and personalized care.

Community pharmacies and pharmacists play a crucial role in improving community health.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

Pioglitazone may help treat lichen planopilaris, but more research is needed.

GLP1-RAs may have higher reports of suicide and hair loss, but no strong evidence links them to these issues.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

Ac-GFFY-IGF peptide is a promising, safe, and effective treatment for hair loss, better than current options.

GLP1-RAs may have higher reports of suicidal events and hair loss compared to other diabetes drugs.